These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13811527)

  • 1. Ammonia tolerance in liver disease.
    CONN HO
    J Lab Clin Med; 1960 Jun; 55():855-71. PubMed ID: 13811527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ammonium tolerance in liver diseases treated with acetazolamide and chlorothiazide].
    GRABNER G; KRYGICZ H; NEUMAYR A; PUXKANDL H
    Wien Z Inn Med; 1960 Mar; 41():81-90. PubMed ID: 13828684
    [No Abstract]   [Full Text] [Related]  

  • 3. Ammonium tolerance in liver disease: observations based on catheterization of the hepatic veins.
    WHITE LP; PHEAR EA; SUMMERSKILL WH; SHERLOCK S
    J Clin Invest; 1955 Feb; 34(2):158-68. PubMed ID: 13233339
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein tolerance in liver disease.
    Leevy CM; Chey WY; Arts PA; Mendenhall CL; Howard MM
    Am J Clin Nutr; 1962 Jan; 10():46-55. PubMed ID: 14463637
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the metabolism of adrenal cortex hormones in liver patients (59 cases)].
    MINOZZI M; FAGGIANO M
    Endocrinol Sci Cost; 1960; 26():294-303. PubMed ID: 13771111
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the effect of some substances on the content of ammonia and glutamine in the brain during functional disorders of the liver].
    GORDON BG
    Tr Inst Fiziol Im I P Pavlova; 1962; 10():294-302. PubMed ID: 13900430
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of alterations in extraction and distribution of colloidal chromic phosphate in patients with liver disease.
    RANKIN JG; PLAYOUST MR; BEAL RW
    J Lab Clin Med; 1961 Dec; 58():920-6. PubMed ID: 14490278
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on disorders of ammonia metabolism in liver diseases. 3. Disorders of ammonia metabolism in liver diseases].
    BOCKEL R; IMLER M; KURTZ D; FRICK A
    Rontgen Laborator; 1962 Jun; 15():L110-L117. PubMed ID: 13870379
    [No Abstract]   [Full Text] [Related]  

  • 9. Malabsorption in chronic parenchymatous liver disease. I. Studies with I 131-labelled triolein.
    SIURALA M; MAKELA TE; HAKKILA J
    Ann Med Intern Fenn; 1960; 49():93-104. PubMed ID: 13831400
    [No Abstract]   [Full Text] [Related]  

  • 10. Discussion on endocrine changes in liver disease.
    SHERLOCK S; LEE J; BISSET GW; SUMMERSKILL WH
    Proc R Soc Med; 1958 May; 51(5):359-64. PubMed ID: 13567678
    [No Abstract]   [Full Text] [Related]  

  • 11. Malabsorption in chronic parenchymatous liver disease. II. Studies with I 131-labelled albumin and I 131-labelled oleic acid.
    SIURALA M; HAKKILA J; MAKELA TE
    Ann Med Intern Fenn; 1960; 49():105-11. PubMed ID: 13831395
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adrenal cortex and diseases of the liver parenchyma].
    ALBRICH E; SPIESS-BERTSCHINGER A
    Act Hepato; 1957 Oct; 5(5-6):I/117-45. PubMed ID: 13478440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Physiological studies of blood coagulation and liver function].
    BROICHER H; EGLI H; KESSELER K
    Dtsch Med Wochenschr; 1960 Feb; 85():350-5. PubMed ID: 13804697
    [No Abstract]   [Full Text] [Related]  

  • 14. [Corticosteroid catabolism and liver function in healthy subjects and in those with liver diseases].
    PFEFFER KH; ROHRBACH W
    Klin Wochenschr; 1960 Jul; 38():650-7. PubMed ID: 14432518
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reactivity of the skin to the intradermoreaction with 48/80 in the healthy subject and in the patient with liver disease].
    FUCCELLA LM; CENACCHI GC; RANDIV ; ROSAL
    Boll Soc Ital Biol Sper; 1961 Nov; 37():1102-4. PubMed ID: 13895621
    [No Abstract]   [Full Text] [Related]  

  • 16. [The cocarboxylase test of the normal relations between endogenous arteriovenous blood alcohol and the pyruvate phase of intermediate metabolism in normal persons and patients with liver disease].
    PANSINI R; RIPA R
    Arcisp S Anna Ferrara; 1961; 14():583-90. PubMed ID: 14483584
    [No Abstract]   [Full Text] [Related]  

  • 17. [REFLECTIONS ON HUMAN TOLERANCE TO ECK'S FISTULA. APROPOS OF 3 CASES].
    AUBERTIN E; AUBERTIN J; WONE C
    J Med Bord; 1963 Nov; 140():1645-74. PubMed ID: 14095315
    [No Abstract]   [Full Text] [Related]  

  • 18. The relative role of extremity, liver, and kidney as ammonia receivers and donors in patients with liver disease.
    TYOR MP; OWEN EE; BERRY JN; FLANAGAN JF
    Gastroenterology; 1960 Oct; 39():420-4. PubMed ID: 13778892
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver disease and antibody formation.
    HAVENS WP
    Int Arch Allergy Appl Immunol; 1959; 14(1-2):75-83. PubMed ID: 13620327
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selective sensitivity to heparin in liver disease patients and in newborn infants].
    MASURE R; MORIAU M
    Rev Belg Pathol Med Exp; 1960 May; 27():169-79. PubMed ID: 13768012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.